Company intelligence / Profile preview

BioScience Valuation

Grainau, Bavaria, Germanybioscience-valuation.com ↗

Ownership: Private
Development stage: Other

Overview

BioScience Valuation provides consulting services at the intersection of life sciences and finance. They specialize in asset valuation, deal support, funding rounds, licensing processes, and strategic advisory for biotech and pharma companies as well as investors. Their expertise includes scientific analysis from molecular to clinical impact and financial modeling for value forecasting.

The company does not conduct clinical trials or have a therapeutic pipeline.

Industry: Consulting

Partnerships

NLC Health VenturesVarious undisclosed partnerships with pharma/biotech clients globally

Beyond the preview

Go deeper on BioScience Valuation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioScience Valuation.

Explore the full profile